A&M STABTEST Shares QC Analysis Of Oligo Therapeutics
Source: Waters Corporation
How A&M STABTEST utilized new technology to respond to sponsors’ needs
Hear from Dr. Thomas Franz, Study Director at A&M STABTEST, as he shares best practices on developing a QC method for identification and impurity analysis of oligonucleotides.
You will learn how to:
- Mitigate risk by using compliant instrumentation and software
- Evaluate various ion-pairing reagents when developing oligonucleotide QC methods
- Identify analytical conditions that impact quality of oligonucleotide data
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
This website uses cookies to ensure you get the best experience on our website. Learn more